Psychiatry and Neurology, Neurology · East Setauket, NY
NPI
1265592943
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
181 N Belle Mead Rd, Suite 5 & 6
East Setauket, NY, 11733
Phone (631) 444-2599
Groups this clinician bills Medicare through
Medicare paid, 2024
$312K
30,217 services
Medicare patients, 2024
584
Average age 75
Drug cost, 2024
$2.3M
2,741 prescriptions
Company payments, 2025
$180
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Guy Schwartz was code J0585 (injection, onabotulinumtoxina, 1 unit), 26,077 times for 53 patients. In total Guy Schwartz billed 30,217 services in 30 codes, and Medicare paid $312K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 26,077 | 53 | $4.97 | $130K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 2,300 | 24 | $10.22 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 505 | 346 | $14.90 | $7,527 |
| 99214 Office E&M - Established | Office | 393 | 264 | $110.85 | $44K |
| 99215 Office E&M - Established | Office | 249 | 197 | $152.90 | $38K |
| 99213 Office E&M - Established | Office | 182 | 146 | $71.70 | $13K |
| 99205 Office E&M - New | Office | 61 | 61 | $203.05 | $12K |
| 64611 Musculoskeletal | Office | 58 | 29 | $122.23 | $7,089 |
| 64616 Musculoskeletal | Office | 48 | 19 | $135.48 | $6,503 |
| 64612 Musculoskeletal | Office | 44 | 17 | $128.89 | $5,671 |
| 64643 Musculoskeletal | Office | 41 | 11 | $89.63 | $3,675 |
| 99204 Office E&M - New | Office | 36 | 36 | $141.45 | $5,092 |
| 64642 Musculoskeletal | Office | 32 | 17 | $150.62 | $4,820 |
| 95970 Electrical Nerve Conductivity | Office | 31 | 20 | $15.34 | $475 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $121.95 | $2,927 |
By year: 2022 $256K for 25,070 services; 2023 $281K for 27,495 services; 2024 $312K for 30,217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Guy Schwartz prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 550 prescriptions and refills. In total Guy Schwartz wrote 2,741 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 550 | 1,398 | 181 | $25K |
| Rasagiline Mesylate Generic | 283 | 744 | 91 | $125K |
| Gocovri Amantadine Hcl | 222 | 286 | 35 | $683K |
| Donepezil Hcl Generic | 217 | 595 | 80 | $2,965 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 165 | 468 | 65 | $14K |
| Rytary Carbidopa/Levodopa | 103 | 261 | 31 | $232K |
| Clonazepam Generic | 90 | 138 | 31 | $1,500 |
| Gabapentin Generic | 89 | 229 | 32 | $1,466 |
| Sertraline Hcl Generic | 88 | 231 | 33 | $546 |
| Amantadine Amantadine Hcl | 71 | 177 | 25 | $7,695 |
| Neupro Rotigotine | 59 | 152 | 16 | $134K |
| Austedo Xr Deutetrabenazine | 54 | 54 | Under 11 | $555K |
| Alprazolam Generic | 53 | 81 | 34 | $257 |
| Selegiline Hcl Generic | 42 | 116 | 15 | $5,904 |
| Mirtazapine Generic | 41 | 111 | 16 | $847 |
Brand drugs: - claims; generic drugs: 2,099 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Guy Schwartz $180 ($180 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boston Scientific Corporation with $104.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.